SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-097931
Filing Date
2014-03-13
Accepted
2014-03-13 17:01:49
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d653044d10k.htm 10-K 962952
2 EX-21.1 d653044dex211.htm EX-21.1 3087
3 EX-23.1 d653044dex231.htm EX-23.1 5886
4 EX-31.1 d653044dex311.htm EX-31.1 9189
5 EX-31.2 d653044dex312.htm EX-31.2 9227
6 EX-32.1 d653044dex321.htm EX-32.1 3786
7 EX-32.2 d653044dex322.htm EX-32.2 3829
14 GRAPHIC g653044tx_stmp37.jpg GRAPHIC 59625
  Complete submission text file 0001193125-14-097931.txt   6859656

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kerx-20131231.xml EX-101.INS 869075
9 XBRL TAXONOMY EXTENSION SCHEMA kerx-20131231.xsd EX-101.SCH 61245
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20131231_cal.xml EX-101.CAL 79738
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20131231_def.xml EX-101.DEF 381472
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20131231_lab.xml EX-101.LAB 495005
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20131231_pre.xml EX-101.PRE 455073
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 14691708
SIC: 2834 Pharmaceutical Preparations